Breaking 20:00 Man arrested after suspected arson attack outside federal building in New York 19:31 NASA says Artemis III remains on track despite Blue Origin setback 17:45 US appeals court overturns class action status in Boeing 737 MAX 9 shareholder lawsuit 15:45 US accuses Cuba of decades-long espionage and subversion campaign 15:36 New York reports three deaths and 74 cases linked to Legionnaires’ disease outbreak 15:10 Trump demands compensation from Canada over Ontario wildfire smoke impact 13:46 US expands electronic warfare capabilities for Morocco’s Apache helicopters 13:45 Tempus to acquire Personalis in $1.5 billion deal to strengthen AI-driven cancer diagnostics 12:15 Trump expresses interest in bringing another World Cup to the United States 12:00 Jd Vance welcomes fourth child after World Cup final 11:30 FIFA's first World Cup final halftime show sparks debate despite star-studded lineup 11:06 Hut 8 secures $9.8 billion AI data center lease to fully commercialize Texas campus 10:31 Meta faces Tennessee trial over claims Instagram was designed to encourage addictive use 10:30 Netanyahu's office condemns New York mayor's remarks over possible arrest during UN General Assembly 10:05 Morgan Stanley expands digital services with direct cryptocurrency trading 09:30 Trump Media considers premium subscription for early access to Trump's Truth Social posts 09:00 New York records second death as Legionnaires' disease outbreak grows 07:30 Nine people injured in Tucson shooting as police investigate motive

Health



Seven U.S. aid workers quarantine in Kenya after new Ebola travel restrictions

Seven American humanitarian workers who recently helped combat the Ebola outbreak in the Democratic Republic of the Congo are undergoing quarantine in Kenya after new U.S. travel restrictions came into effect. According to the head of a U.S.-based humanitarian organization employing the workers, the......

United States imposes travel restrictions amid Ebola outbreak in the Democratic Republic of the Congo

The United States has introduced new travel restrictions for individuals arriving from the Democratic Republic of the Congo (DRC) as health authorities seek to reduce the risk of Ebola entering the country amid an ongoing outbreak. Under the new measures, travelers who have recently been in the DRC......

United States restricts air travel from DR Congo amid Ebola outbreak

The United States has introduced temporary travel restrictions affecting American citizens departing from the Democratic Republic of the Congo (DR Congo) as health authorities respond to the country's ongoing Ebola outbreak. According to US officials, American citizens who have recently been in......

Legionnaires' disease outbreak in New York sickens 60 as investigation expands

Health officials in New York City are continuing to investigate an outbreak of Legionnaires' disease that has infected 60 people, prompting an extensive public health response and expanded environmental testing across affected neighborhoods. According to local health authorities, dozens of patients......

US Ebola patient infected in Congo transferred to specialized hospital in Germany

A U.S. citizen infected with the Bundibugyo strain of the Ebola virus in the Democratic Republic of the Congo has been admitted to a high-security isolation unit at Frankfurt University Hospital, German officials confirmed on Monday. The patient was transferred to Germany for specialist treatment after......

United States warns Europe over Ebola travel rules escalation

Marco Rubio held a call with Ursula von der Leyen to coordinate the response between Washington and Brussels over the Ebola outbreak spreading in the Democratic Republic of the Congo and Uganda. The United States urged European authorities to strengthen travel controls or face possible restrictions on......

Germany approves first cannabis-based chronic pain medication Exilby

A biopharmaceutical company has secured regulatory approval in Germany and Austria for a cannabis-derived oral treatment targeting chronic lower back pain with neuropathic features. The product, Exilby (VER-01), becomes the first cannabis-based medicine explicitly authorized for chronic pain management......

Johnson & Johnson wins lawsuit over talc-related cancer claims

Johnson & Johnson has secured a legal victory in a high-profile lawsuit involving allegations that its talc-based products caused ovarian cancer. A jury in Los Angeles ruled in favor of the healthcare giant, concluding that the company was not negligent in the marketing and sale of its cosmetic talc......

U.S. treatment centers prepared for Ebola as global outbreak concerns persist

Hospitals across the United States that specialize in high-risk infectious diseases are reportedly prepared to treat Ebola patients if necessary, even as concerns remain over ongoing outbreak responses in Africa and planning efforts in other regions such as Kenya. Officials from a federally funded network......

United States to Re-engage with Gavi vaccine alliance amid Ebola outbreak, Rubio says

The United States has announced that it will resume its cooperation with the global vaccine partnership Gavi, the Vaccine Alliance, following growing concerns over an Ebola outbreak affecting several African countries. U.S. Secretary of State Marco Rubio stated during a Senate Foreign Relations Committee......

Kenya defends U.S.-backed Ebola quarantine facility amid public concerns

Kenyan authorities have defended plans to establish a U.S.-supported Ebola quarantine facility at a military air base, arguing that the project forms part of broader efforts to strengthen public health preparedness and emergency response capabilities. The initiative has generated considerable public......

J&J injectable cancer drug eliminates tumors in head and neck cancer patients

Results from an international clinical trial presented at the annual meeting of the American Society of Clinical Oncology show that a subcutaneous cancer injection can eradicate or reduce tumors in patients who have exhausted standard treatment options. The phase Ib/II OrigAMI-4 trial evaluated subcutaneous......

Akeso lung cancer drug cuts death risk by 34 percent in major clinical trial

A experimental lung cancer drug developed by Chinese biopharmaceutical company Akeso reduced the risk of death by 34 percent compared to an established immunotherapy, according to results presented Saturday at the annual meeting of the American Society of Clinical Oncology. The findings mark a significant......

  • Fajr
  • Sunrise
  • Dhuhr
  • Asr
  • Maghrib
  • Isha

This website, walaw.press, uses cookies to provide you with a good browsing experience and to continuously improve our services. By continuing to browse this site, you agree to the use of these cookies.